يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Efthalia Lalla"', وقت الاستعلام: 1.28s تنقيح النتائج
  1. 1
    Abstract P2-09-10: Different CNVs account for 10.4% of pathogenic variants in 1418 patients referred for hereditary breast cancer testing

    المؤلفون: Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Georgia Pepe, Eirini Papadopoulou, Georgios N Tsaousis, Despina Apostolopoulou, Angeliki Meintani, Vassileios Venizelos, Christos Markopoulos, Rodoniki Iosifidou, Sofia Karageorgopoulou, Christos Christodoulou, Ioannis Natsiopoulos, Konstantinos Papazisis, Maria Vasilaki-Antonatou, Eleftherios Kabletsas, Amanta Psyrri, Stylianos Giassas, Dimitrios Ziogas, Efthalia Lalla, Anna Koumarianou, Christos Papadimitriou, Vahit Ozmen, Sualp Tansan, Kerim Kaban, Tahsin Ozatlı, Dan Tudor Eniu, Angelica Chiorean, Alexandru Blidaru, George Nasioulas

    المصدر: Cancer Research. 82:P2-09

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2e652b4291efab80aadabf3c48fd4018Test
    https://doi.org/10.1158/1538-7445.sabcs21-p2-09-10Test


    أضف إلى المفضلة
  2. 2
    An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece

    المؤلفون: Dimitrios Bafaloukos Snr, Athina Christopoulou, Anastasios Boutis, Gerasimos Aravantinos, Georgia-Angeliki Koliou, Sofia Lampaki, Helena Linardou, George Fountzilas, Panagiotis Papantoniou, Efthalia Lalla, Eleni Res, Nicoleta Pastelli, Margarita-Ioanna Koufaki, Georgios Rigakos, Pavlos Papakotoulas, Giannis Mountzios, Dionisios Spyratos, Anna Koumarianou, Anastasios Grivas, Athanassios Vozikis, Georgios Oikonomopoulos, Ioannis Kontogiorgos

    المصدر: Lung Cancer: Targets and Therapy
    Lung Cancer: Targets and Therapy, Vol Volume 12, Pp 93-102 (2021)

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cost effectiveness, Afatinib, EGFR, Targets and Therapy [Lung Cancer], afatinib, molecular epidemiology, epidermal growth factor receptor (egfr), Internal medicine, medicine, Epidermal growth factor receptor, Lung cancer, cost-effectiveness, RC254-282, Original Research, biology, Performance status, business.industry, molecular epidemiol-ogy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Retrospective cohort study, medicine.disease, Clinical trial, lung cancer, Tolerability, biology.protein, business, epidermal growth factor receptor, medicine.drug

    وصف الملف: text/html

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaae6c4e1bec22d7a5f9e1d4ebb24e49Test
    http://europepmc.org/articles/PMC8415762Test


    أضف إلى المفضلة
  3. 3
    Prognostic Significance of Low HER2 Expression in Patients With Metastatic Hormone Receptor-positive Breast Cancer Treated With First Line CDK4/6 Inhibitors: A Greek Multicenter Real-world Data Analysis

    المؤلفون: GEORGE DOUGANIOTIS, GEORGE KESISIS, EFTHALIA LALLA, IPPOKRATIS KORANTZIS, IOANNIS BOUKOVINAS, KONSTANTINOS PAPAZISIS

    المصدر: Cancer Diagn Progn

    مصطلحات موضوعية: Research Article

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a51d4d0f9681c5050e95e0608da8f0Test
    https://pubmed.ncbi.nlm.nih.gov/36060026Test


    أضف إلى المفضلة
  4. 4
    Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

    المؤلفون: Helena Linardou, Efthalia Lalla, Georgios Koumakis, Georgia-Angeliki Koliou, Sofia Karteri, Evangelia Razis, Davide Mauri, George Fountzilas, Sofia Karageorgopoulou, Anna Koumarianou, Eleni Res, Gerasimos Aravantinos, Athina Christopoulou, Ioannis Boukovinas, Vassiliki Rapti, D. Tryfonopoulos, Evangelia Moirogiorgou, Amanda Psyrri, Athanassios Vozikis, Dimitrios Bafaloukos, Zacharenia Saridaki, Elena Fountzilas, Adamantia Nikolaidi, I. Binas, Giannis Mountzios, Anastasios Boutis, Ioannis Kontogiorgos, Flora Zagouri, Cleopatra Rapti, Achilleas Nikolakopoulos

    المصدر: ESMO Open

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Breast Neoplasms, Endocrine System, Neutropenia, aromatase inhibitors, Breast cancer, Pharmacotherapy, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Humans, health economics, Medicine, Prospective Studies, real-world evidence, Adverse effect, Aged, Retrospective Studies, Original Research, business.industry, Cyclin-Dependent Kinase 4, Cancer, Cyclin-Dependent Kinase 6, Middle Aged, medicine.disease, Toxicity, endocrine treatment, Female, hormone receptor-positive, business, Adverse drug reaction

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47fc60321c69b3e37b0e0d540ee9ab7cTest
    https://doi.org/10.1136/esmoopen-2020-000774Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث